Emergent BioSolutions Inc. — Director's Dealing 2018

Nov 5, 2018

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: Emergent BioSolutions Inc. (EBS)
CIK: 0001367644
Period of Report: 2018-11-01

Reporting Person: Havey Adam (EVP, Business Operations)

Non-Derivative Transactions

Date	Security	Code	Shares	Price	A/D	Holdings After	Ownership
2018-11-01	Common Stock	M	2011	$25.62	Acquired	31264	Direct
2018-11-01	Common Stock	S	2011	$63.50	Disposed	29253	Direct
2018-11-02	Common Stock	M	6168	$25.62	Acquired	35421	Direct
2018-11-02	Common Stock	S	6168	$64.50	Disposed	29253	Direct

Derivative Transactions

Date	Security	Exercise Price	Code	Shares	A/D	Expiration	Underlying	Ownership
2018-11-01	Stock Option (Right to Buy)	$25.62	M	2011	Acquired	2021-03-10	Common Stock (2011)	Direct
2018-11-02	Stock Option (Right to Buy)	$25.62	M	6168	Acquired	2021-03-10	Common Stock (6168)	Direct

Footnotes

F1: The transactions reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by Mr. Havey.

F2: Consists of an option granted under the company's stock incentive plan as amended and restated.

F3: The option grant vested in three equal installments on the day prior to the first, second and third anniversary dates of the grant.